Furthermore, our western blot results also showed that TFAP4 could not regulate the activation of GSK3β and NF-κB after inhibiting the PI3K/AKT signaling pathway with LY294002, nor could it promote the invasion and metastasis of HCC. The gene discussed is GSK3B; the disease is hepatocellular carcinoma.